FDA Inspection 1025042 — The Queen's Medical Center IRB
The FDA completed an inspection of The Queen's Medical Center IRB on July 21, 2017 in Honolulu, HI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Honolulu, HI (United States)
Additional Details
IRB